ELDN
Price
$1.90Alerts
Change
-$0.14 (-6.90%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
211.69M
133 days until earnings call
Intraday BUY SELL Signals
FDMT
Price
$10.72Alerts
Change
+$0.26 (+2.49%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
676.74M
99 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELDN vs FDMT

ELDN vs FDMT Comparison Chart in %
View a ticker or compare two or three
VS
ELDN vs. FDMT commentary
Nov 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELDN is a Hold and FDMT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ELDN with price predictions
Nov 18, 2026

ELDN in downward trend: price dove below 50-day moving average on November 12, 2026

ELDN moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend. In 41 of 44 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ELDN moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 22 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.

The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ELDN as a result. In 70 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.

The Moving Average Convergence Divergence Histogram (MACD) for ELDN turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 40 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.

The 10-day moving average for ELDN crossed bearishly below the 50-day moving average on November 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELDN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for ELDN entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELDN advanced for three days, in 219 of 249 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

ELDN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. ELDN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.412) is normal, around the industry mean (3.592). P/E Ratio (-2.894) is within average values for comparable stocks, (-1.190). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.305) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (442.120).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELDN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for FDMT with price predictions
Nov 18, 2026

FDMT's Indicator enters downward trend

The Aroon Indicator for FDMT entered a downward trend on November 04, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 220 similar instances where the Aroon Indicator formed such a pattern. In 192 of the 220 cases the stock moved lower. This puts the odds of a downward move at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FDMT as a result. In 76 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

The Moving Average Convergence Divergence Histogram (MACD) for FDMT turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 38 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FDMT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FDMT's RSI Indicator exited the oversold zone, 20 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +10.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where FDMT advanced for three days, in 217 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

FDMT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.660) is normal, around the industry mean (3.592). P/E Ratio (-4.658) is within average values for comparable stocks, (-1.190). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.305) among similar stocks. P/S Ratio (9.662) is also within normal values, averaging (442.120).

The Tickeron PE Growth Rating for this company is 61 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. FDMT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FDMT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
ELDN vs FDMT: Fundamental Ratings
ELDN
FDMT
OUTLOOK RATING
1..100
9114
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6461
P/E GROWTH RATING
1..100
1461
SEASONALITY SCORE
1..100
2875

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FDMT's Valuation (24) in the null industry is somewhat better than the same rating for ELDN (72) in the Pharmaceuticals Major industry. This means that FDMT’s stock grew somewhat faster than ELDN’s over the last 12 months.

FDMT's Profit vs Risk Rating (100) in the null industry is in the same range as ELDN (100) in the Pharmaceuticals Major industry. This means that FDMT’s stock grew similarly to ELDN’s over the last 12 months.

FDMT's SMR Rating (97) in the null industry is in the same range as ELDN (100) in the Pharmaceuticals Major industry. This means that FDMT’s stock grew similarly to ELDN’s over the last 12 months.

FDMT's Price Growth Rating (61) in the null industry is in the same range as ELDN (64) in the Pharmaceuticals Major industry. This means that FDMT’s stock grew similarly to ELDN’s over the last 12 months.

ELDN's P/E Growth Rating (14) in the Pharmaceuticals Major industry is somewhat better than the same rating for FDMT (61) in the null industry. This means that ELDN’s stock grew somewhat faster than FDMT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELDNFDMT
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
COMPARISON
Comparison
Nov 19, 2026
Stock price -- (ELDN: $2.03 vs. FDMT: $10.46)
Brand notoriety: ELDN and FDMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELDN: 108% vs. FDMT: 58%
Market capitalization -- ELDN: $211.69M vs. FDMT: $676.74M
ELDN [@Biotechnology] is valued at $211.69M. FDMT’s [@Biotechnology] market capitalization is $676.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELDN’s FA Score shows that 1 FA rating(s) are green while FDMT’s FA Score has 1 green FA rating(s).

  • ELDN’s FA Score: 1 green, 4 red.
  • FDMT’s FA Score: 1 green, 4 red.
According to our system of comparison, FDMT is a better buy in the long-term than ELDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELDN’s TA Score shows that 3 TA indicator(s) are bullish while FDMT’s TA Score has 4 bullish TA indicator(s).

  • ELDN’s TA Score: 3 bullish, 7 bearish.
  • FDMT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FDMT is a better buy in the short-term than ELDN.

Price Growth

ELDN (@Biotechnology) experienced а -23.97% price change this week, while FDMT (@Biotechnology) price change was -19.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.39%. For the same industry, the average monthly price growth was -12.15%, and the average quarterly price growth was -24.55%.

Reported Earning Dates

ELDN is expected to report earnings on Apr 01, 2027.

FDMT is expected to report earnings on Feb 26, 2027.

Industries' Descriptions

@Biotechnology (-5.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ELDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELDN has been loosely correlated with EDIT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ELDN jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELDN
1D Price
Change %
ELDN100%
+2.53%
EDIT - ELDN
51%
Loosely correlated
-3.01%
BEAM - ELDN
51%
Loosely correlated
+1.74%
NTLA - ELDN
47%
Loosely correlated
-0.10%
CADL - ELDN
47%
Loosely correlated
-1.48%
FDMT - ELDN
44%
Loosely correlated
-3.06%
More

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with KYTX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
-3.06%
KYTX - FDMT
59%
Loosely correlated
-4.68%
PRME - FDMT
55%
Loosely correlated
-0.52%
RCKT - FDMT
55%
Loosely correlated
N/A
EDIT - FDMT
55%
Loosely correlated
-3.01%
SLDB - FDMT
54%
Loosely correlated
+1.93%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SLYG108.100.92
+0.86%
State Street SPDR S&P 600 Small Cap Growth ETF (SLYG)
FNY95.200.70
+0.74%
First Trust Mid Cap Growth AlphaDEX Fund (FNY)
ADDS25.40N/A
N/A
Hedgeye Index Adds ETF (ADDS)
IBIH25.07-0.02
-0.08%
iShares iBonds Oct 2031 Term TIPS ETF (IBIH)
YLDW24.02-0.04
-0.15%
Westwood Enhanced Income Opportunity ETF (YLDW)